ML23117A065

From kanterella
Revision as of 09:37, 8 May 2023 by StriderTol (talk | contribs) (StriderTol Bot insert)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Kairos Non-Power Reactor Hermes Construction Permit Application - Safety Evaluation for Chapter 16, Other License Considerations
ML23117A065
Person / Time
Site: 99902069, Hermes
Issue date: 04/27/2023
From: Halnon G
Advisory Committee on Reactor Safeguards
To: David Petti
Advisory Committee on Reactor Safeguards
References
Download: ML23117A065 (1)


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION ADVISORY COMMITTEE ON REACTOR SAFEGUARDS WASHINGTON, DC 20555 - 0001 April 27, 2023 MEMORANDUM TO: David Petti, Lead Kairos Hermes License Application Review Subcommittee Advisory Committee on Reactor Safeguards FROM: Greg Halnon, Member Advisory Committee on Reactor Safeguards

SUBJECT:

INPUT FOR ACRS REVIEW OF THE KAIROS CONSTRUCTION PERMIT APPLICATION - DRAFT SAFETY EVALUATION FOR CHAPTER 16, OTHER LICENSE CONSIDERATIONS In response to the Subcommittees request, I have reviewed the NRC staffs safety evaluation (SE) with no open items for Chapter 16, Other License Considerations. The following is my recommended course of action concerning further review of this chapter and the staffs associated SE.

Background

This chapter captures license considerations that are unique to this technology that do not belong elsewhere in the preliminary safety analysis report (PSAR). This includes how reactor components may have been used in the past and any use of the nuclear process for medical purposes.

SE Summary Chapter 16 of the applicants PSAR was found to be of sufficient detail to provide confidence that the other license considerations will not be applicable to the Hermes reactor. The staff concluded there is no need for further review since the applicant stated all the material used in the construction and operation of the reactor plant and support systems will be new components (i.e., never used before) and there will be no medical use of the reactor plant associated with the direct medical administration of radioisotopes or other radiation-based therapies.

Discussion I have no concerns with either the applicants description or the staffs conclusion. No further review is necessary unless the considerations are changed by the applicant.

Recommendation(s)

I recommend no further action.

D. Petti References

1. USNRC, Draft Safety Evaluation for Hermes NonPower Reactor Preliminary Safety Analysis Report Chapter 16, January 2023 (ML23017A120)
2. Kairos Power LLC, Submittal of the Preliminary Safety Analysis Report for the Kairos Power Fluoride Salt-Cooled, High Temperature Non-Power Reactor (Hermes), Revision 2, February 2023 (ML23055A672)
3. USNRC, NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Format and Content, issued February 1996 (ML042430055)
4. USNRC, NUREG-1537, Part 2, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors, Standard Review Plan and Acceptance Criteria, issued February 1996 (ML042430048)

D. Petti April 27, 2023

SUBJECT:

INPUT FOR ACRS REVIEW OF THE KAIROS CONSTRUCTION PERMIT APPLICATION - DRAFT SAFETY EVALUATION FOR CHAPTER 16, OTHER LICENSE CONSIDERATIONS Package No: ML23117A000 Memo Accession No: ML23117A065 Publicly Available Y Sensitive N Viewing Rights: NRC Users or ACRS Only or See Restricted distribution *via e-mail OFFICE ACRS/TSB* SUNSI Review* ACRS/TSB* ACRS*

NAME WWang WWang LBurkhart (WWang for) GHalnon DATE 4/27/2023 4/27/2023 4/27/2023 4/27/2023 OFFICIAL RECORD COPY